Flagship Harbor Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-516
Closed -$25K 1972
2025
Q4
$25K Buy
+516
New +$25.6K ﹤0.01% 1264
2020
Q4
Sell
-219
Closed -$11K 1578
2020
Q3
$11K Buy
219
+55
+34% +$2.83K ﹤0.01% 1309
2020
Q2
$8K Buy
164
+2
+1% +$97 ﹤0.01% 1446
2020
Q1
$7K Sell
162
-709
-81% -$33.9K ﹤0.01% 1346
2019
Q4
$44K Hold
871
0.01% 859
2019
Q3
$40K Sell
871
-509
-37% -$22K 0.01% 847
2019
Q2
$59K Buy
1,380
+320
+30% +$13.6K 0.01% 718
2019
Q1
$46K Sell
1,060
-489
-32% -$20.9K 0.01% 778
2018
Q4
$67K Sell
1,549
-5,270
-77% -$232K 0.02% 632
2018
Q3
$307K Sell
6,819
-4,628
-40% -$198K 0.06% 313
2018
Q2
$458K Buy
+11,447
New +$451K 0.09% 232

Other funds holding SNY

Flagship Harbor Advisors's SNY Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Sanofi (SNY) in Q1 2026, closing a stake of 516 shares — an estimated $25K sold.

Flagship Harbor Advisors first reported a position in SNY in Q2 2018 and held it in 11 quarters. The position peaked at $458K in Q2 2018. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 516 Sanofi shares in Q1 2026, an estimated $25K.
  • Flagship Harbor Advisors first reported a position in Sanofi in Q2 2018 and held it in 11 quarters.
  • Flagship Harbor Advisors's Sanofi position peaked at $458K in Q2 2018.
  • 745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.